These Healthcare stocks are trading higher:
-Jasper Therapeutics Inc (JSPR) stock is trading at $2.98, a rise of $2.5, or 500.54%, on high volume. Jasper Therapeutics Inc. gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $7.33.
-ReShape Lifesciences Inc (RSLS) stock is trading at $15.26, an increase of $8.52, or 126.41%, on high volume. ReShape Lifesciences Inc. gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $68.75.
-180 Life Sciences Corp (ATNF) stock is trading at $5.68, a gain of $2.29, or 66.37%, on high volume. 180 Life Sciences Corp. gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $80.00.
-Immunome Inc (IMNM) stock is trading at $3.19, an increase of $0.98, or 44.34%, on high volume. Immunome Inc. gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $8.50.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Biora Therapeutics Inc (BIOR) stock is trading at $2.44, a decline of $0.86, or 26.01%, on low volume. Biora Therapeutics Inc. gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.00.
-Palisade Bio Inc (PALI) stock is trading at $4.05, a drop of $1.15, or 22.12%, on average volume. Palisade Bio Inc. gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $25.00.
-Cano Health Inc (CANO) stock is trading at $1.11, a decline of $0.26, or 19.34%, on low volume. Cano Health Inc. Class A gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $6.28.
-Prelude Therapeutics Inc (PRLD) stock is trading at $4.95, a loss of $1.09, or 18.05%, on average volume. Prelude Therapeutics Incorporated gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $10.60.
Find the top stocks in the Healthcare Sector here.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
